Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma.

Endersby R, Whitehouse J, Pribnow A, Kuchibhotla M, Hii H, Carline B, Gande S, Stripay J, Ancliffe M, Howlett M, Schoep T, George C, Andradas C, Dyer P, Schluck M, Patterson B, Tacheva-Gigorova SK, Cooper MN, Robinson G, Stewart C, Pfister SM, Kool M, Milde T, Gajjar A, Johns T, Wechsler-Reya RJ, Roussel MF, Gottardo NG

Open source

DOI: 10.1126/scitranslmed.aba7401
Published: 2021 Jan 20
Container: Science translational medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1126/scitranslmed.aba7401,
  title = {Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma.},
  author = {Endersby R and Whitehouse J and Pribnow A and Kuchibhotla M and Hii H and Carline B and Gande S and Stripay J and Ancliffe M and Howlett M and Schoep T and George C and Andradas C and Dyer P and Schluck M and Patterson B and Tacheva-Gigorova SK and Cooper MN and Robinson G and Stewart C and Pfister SM and Kool M and Milde T and Gajjar A and Johns T and Wechsler-Reya RJ and Roussel MF and Gottardo NG},
  year = {2021},
  journal = {Science translational medicine},
  doi = {10.1126/scitranslmed.aba7401},
  url = {https://doi.org/10.1126/scitranslmed.aba7401}
}

RIS

TY  - JOUR
TI  - Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma.
AU  - Endersby R
AU  - Whitehouse J
AU  - Pribnow A
AU  - Kuchibhotla M
AU  - Hii H
AU  - Carline B
AU  - Gande S
AU  - Stripay J
AU  - Ancliffe M
AU  - Howlett M
AU  - Schoep T
AU  - George C
AU  - Andradas C
AU  - Dyer P
AU  - Schluck M
AU  - Patterson B
AU  - Tacheva-Gigorova SK
AU  - Cooper MN
AU  - Robinson G
AU  - Stewart C
AU  - Pfister SM
AU  - Kool M
AU  - Milde T
AU  - Gajjar A
AU  - Johns T
AU  - Wechsler-Reya RJ
AU  - Roussel MF
AU  - Gottardo NG
PY  - 2021
JO  - Science translational medicine
DO  - 10.1126/scitranslmed.aba7401
UR  - https://doi.org/10.1126/scitranslmed.aba7401
ER  -

APA

R, E., J, W., A, P., M, K., H, H., B, C., S, G., J, S., M, A., M, H., T, S., C, G., C, A., P, D., M, S., B, P., SK, T., MN, C., G, R., C, S., SM, P., M, K., T, M., A, G., T, J., RJ, W., MF, R., & NG, G. (2021). Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma.. Science translational medicine. https://doi.org/10.1126/scitranslmed.aba7401

Source records

pubmed · retrieved 2026-09-27T11:55:26.143Z